About Propafenone Hydrochloride
Class: | Antiarrhythmic agent (Class IC)
Use: | Treatment of ventricular tachycardia and prevention of paroxysmal atrial fibrillation and atrial flutter
Adult dose: | Initial dose of 150 mg orally every 8 hours; may be increased to 300 mg every 8 hours based on clinical response
Pediatric dose: | Safety and efficacy not established in pediatric patients; use is not recommended
Side effects: | Dizziness, fatigue, nausea, vomiting, constipation, blurred vision, and potential for proarrhyth
Drug Class
Antiarrhythmic agent (Class IC)
Uses & Indications
Treatment of ventricular tachycardia and prevention of paroxysmal atrial fibrillation and atrial flutter
Storage Requirements
Store at room temperature (20-25°C or 68-77°F) in a tightly closed container, protected from moisture and light
Manufacturer & Packaging
Manufacturer: ANI Pharmaceuticals, Inc., United States of America
Package Size
100's
Price & Supplier
Price in UAE: AED 76.16
Dosage Information
Adult Dose
Initial dose of 150 mg orally every 8 hours; may be increased to 300 mg every 8 hours based on clinical response
Pediatric Dose
Safety and efficacy not established in pediatric patients; use is not recommended
Side Effects
Dizziness, fatigue, nausea, vomiting, constipation, blurred vision, and potential for proarrhythmia
Contraindications & Precautions
Known hypersensitivity to propafenone, history of severe bronchospasm, heart block (unless a pacemaker is present), and significant hypotension
Important Warnings
Monitor for signs of worsening heart failure, hepatic impairment, and potential drug interactions; caution in patients with structural heart disease or significant conduction abnormalities
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.